Global Rheumatoid Arthritis Stem Cell Therapy Market, By Product Type (Allogeneic Mesenchymal Stem Cells, Bone Marrow Transplant and Adipose Tissue Stem Cells), By End-User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2030

Report Code: PMI481521 | Publish Date: May 2023 | No. of Pages: 168

Global Rheumatoid Arthritis Stem Cell Therapy Market Overview

Rheumatoid Arthritis Stem Cell Therapy Market has been shown to stimulate remarkable healing activity, stop arthritic diseases, and, in many cases, reverse and repair joint tissue. Rheumatoid arthritis stem cell therapy now includes bone marrow transplant, adipose or fat-derived stem cells, and allogeneic mesenchymal stem cells (human umbilical cord tissue). As rheumatoid arthritis progresses, the body responds by launching an autoimmune attack on the cells. Rheumatoid arthritis stem cell therapy is becoming increasingly popular in hospitals, ambulatory surgical centres, and specialised clinics because it improves joint repair and treats the entire system that causes joint pain and inflammation. It is possible to screen and select stem cells with the ability to induce regeneration, immunological regulating capabilities, and high anti-inflammatory activity. Furthermore, umbilical cord tissue has a large number of mesenchymal stem cells. These are some of the most important elements that contribute to the onset of rheumatoid arthritis. Rheumatoid arthritis is an autoimmune disease that affects one of the various kinds of arthritis. The immune system assaults diverse areas of joints in people with rheumatoid arthritis by creating cellular reactions and antibodies to numerous tissues, including collagen, causing joint degradation as well as consequences such as heart damage and pulmonary fibrosis.Rheumatoid arthritis is a disease that affects one percent of the world's population. Unfortunately, the existing therapies have side effects since they block immune system responses in a non-specific manner. Rheumatoid arthritis stem cell therapy is an alternate treatment approach that promotes healing while also repairing healthy tissue.

Global Rheumatoid Arthritis Stem Cell Therapy Market Dynamics

Rising prevalence and recurrence of rheumatoid arthritis will drive the growth of the Market

Over the forecast period, the rising prevalence and recurrence of rheumatoid arthritis is likely to be the primary driver of the rheumatoid arthritis stem cell therapy market. Although doctors are unsure of the specific aetiology of rheumatoid arthritis, some risk factors have been linked to the disease. Age (most prevalent between the ages of 40 and 60), family history, gender, environment (a harmful chemical in the environment might increase the likelihood), obesity, and smoking are all risk factors.Rheumatoid arthritis is becoming more common due to changes in lifestyle and food habits. Another element driving the global rheumatoid arthritis stem cell therapy market is the development and inclusion of novel medicines. For example, TiGenix, a Belgian business, recently revealed the results of a randomised phase II trial of their Cx611 adipose-derived stem cell product.

Access Crucial Insights at a Fraction of the Cost | Request Your Discount

Global Rheumatoid Arthritis Stem Cell Therapy Market Segmentation

 

                                                                Source: Prophecy Market Insights |Disclaimer: Data is only a representation. Actual data may vary in the final report.

The Global Rheumatoid Arthritis Stem Cell Therapy Market is segmented based on product type, end-user and region.

On the basis of Product Type, the Global Rheumatoid Arthritis Stem Cell Therapy Market is segmented into Allogeneic Mesenchymal Stem Cells, Bone Marrow Transplant and Adipose Tissue Stem Cells. Based on End-User, the target market is segmented into Hospitals, Ambulatory Surgical Centers and Specialty Clinics.

Regional Insights:

 

                                                                                                                             Source: Prophecy Market Insights

                                           

On region the Global Rheumatoid Arthritis Stem Cell Therapy Market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Because of the presence of several significant companies, North America is likely to be the prominent region in the global rheumatoid arthritis stem cell treatment market. Due to the increase of product offerings by key players, the rheumatoid arthritis stem cell therapy market in Asia Pacific excluding Japan is predicted to rise at a considerable CAGR. Throughout the projected period, Europe is expected to hold the second largest share of the worldwide rheumatoid arthritis stem cell therapy market.

Reduce costs by up to 30% with a custom report tailored to your specific needs | Request Customized Report

Report Scope:

Attribute

Details

Base year for estimation

2020

Forecast period

2020 – 2030

Market representation

Revenue in USD Million & CAGR from 2020 – 2029

Market Segmentation

By Product Type- Allogeneic Mesenchymal Stem Cells, Bone Marrow Transplant and Adipose Tissue Stem Cells

By End-User– Hospitals, Ambulatory Surgical Centers and Specialty Clinics

Regional scope

North America - U.S., Canada

Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe

Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific

Latin America - Brazil, Mexico, Argentina, Rest of Latin America

Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2019 to 2029. For the purpose of this study, has segmented the Global Rheumatoid Arthritis Stem Cell Therapy Market report based on Product Type, End-User and region.

Global Rheumatoid Arthritis Stem Cell Therapy Market, By Region:

      • North America
          • U.S.
          • Canada
      • Europe
          • Germany
          • UK
          • France
          • Russia
          • Italy
          • Rest of Europe
      • Asia Pacific
          • China
          • India
          • Japan
          • South Korea
          • Rest of Asia Pacific
      • Latin America
          • Brazil
          • Mexico
          • Rest of Latin America
      • Middle East & Africa
          • GCC
          • Israel
          • South Africa
          • Rest of Middle East & Africa

Global Rheumatoid Arthritis Stem Cell Therapy Market Key Players

The key players operating in the Global Rheumatoid Arthritis Stem Cell Therapy Market are Mesoblast Ltd., Roslin Cells, Regeneus Ltd, ReNeuron Group plc, International Stem Cell Corporation, TiGenix and others

Global Rheumatoid Arthritis Stem Cell Therapy Market Company Profile

  • Mesoblast Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Roslin Cells
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Regeneus Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ReNeuron Group plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • International Stem Cell Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • TiGenix
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies

Global Rheumatoid Arthritis Stem Cell Therapy Market Table of Contents

  1. Research Objective and Assumption
    • Preface
    • Research Objectives
    • Study Scope
    • Years Considered for the study
    • Assumptions
    • Abbreviations
  2. Research Methodology
    • Research data
    • Primary Data
      • Primary Interviews
      • Primary Breakdown
      • Key data from Primary Sources
      • Key Thickness Insights
    • Secondary Data
      • Major Secondary Sources
      • Secondary Sources
    • Market Estimation
    • Top-Down Approach
      • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
    • Bottom-Up Approach
      • Approach for estimating market share by Bottom-up Analysis (Demand Side)
    • Market Breakdown and Data Triangulation
    • Research Assumptions
  3. Market Purview
    • Executive Summary
    • Key Findings—Global Outlook for Rheumatoid Arthritis Stem Cell Therapy Strategies
      • Key Questions this Study will Answer
      • Market Snippet, By Product Type
      • Market Snippet, By End-User
    • Opportunity Map Analysis
    • Executive Summary—3 Big Predictions
  4. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
      • Market Trends
    • DR Impact Analysis
    • PEST Analysis
    • Porter’s Five Forces Analysis
    • Opportunity Orbit
    • Market Investment Feasibility Index
    • Macroeconomic Factor Analysis
  5. Global Rheumatoid Arthritis Stem Cell Therapy Market, By Product Type, 2020 – 2030, (US$ Mn)
    • Overview                                                                         
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Allogeneic Mesenchymal Stem Cells
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Bone Marrow Transplant
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Adipose Tissue Stem Cells
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  6. Global Rheumatoid Arthritis Stem Cell Therapy Market, By End-User, 2020 – 2030, (US$ Mn)
    • Overview                                                     
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Segment Trends
    • Hopsitals
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Ambulatory Surgical Cneters
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
    • Specialty Clinics
      • Overview
      • Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
  7. Global Rheumatoid Arthritis Stem Cell Therapy Market, By Region, 2020 – 2030, (US$ Mn)
    • Overview
      • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
      • Y-o-Y Growth Analysis (%), 2020 – 2030
      • Regional Trends
    • North America
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • U.S.
        • Canada
    • Europe
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • UK
        • France
        • Germany
        • Russia
        • Italy
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • India
        • Japan
        • South Korea
        • China
        • Rest of Asia Pacific
    • Latin America
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • Brazil
        • Mexico
        • Rest of Latin America
    • Middle East & Africa
      • Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By End-User, 2020 – 2030
      • Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
        • GCC
        • Israel
        • South Africa
        • Rest of Middle East
  8. Competitive Landscape
    • Heat Map Analysis
    • Market Presence and Specificity Analysis
  9. Company Profiles
  • Mesoblast Ltd.
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Roslin Cells
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • Regeneus Ltd
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • ReNeuron Group plc
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • International Stem Cell Corporation
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  • TiGenix
    • Company Overview
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Business Strategies
  1. The Last Word
    • Future Impact
    • About Us
    • Contact

FAQs

Global Rheumatoid Arthritis Stem Cell Therapy Market is segmented based on product type, end-user and region.

Rising prevalence and recurrence of rheumatoid arthritis is major factor driving the market.

During the forecast period, North America is expected to dominate the market.

The key players operating in the Global Rheumatoid Arthritis Stem Cell Therapy Market are Mesoblast Ltd., Roslin Cells, Regeneus Ltd, ReNeuron Group plc, International Stem Cell Corporation, TiGenix and others.